HARapan kiTa ECP (External Counter Pulsation) Study HARTEC Study

Status Recruiting

Clinical Trial Summary

External Counterpulsation Therapy (ECP) is a therapeutic procedure that performed on patients with angina or heart failure to relieve the ischaemic symptoms, improve functional capacity, and quality of life. In recent studies, ECP has already proved to reduce angina symptoms, decrease degree of ischemic in heart train test. External Counterpulsation Therapy (ECP) therapy is a non-invasive technique for sequentially pressuring calf, lower thighs, and upper thighs through developed cuffs at pressure above systolic blood pressure when diastole, then deflated at systole.

Clinical Trial Description

This study aims to evaluate the effect of ECP therapy on cardiovascular hemodynamic, coronary perfusion, endothelial function, angiogenesis and artery genesis of the coronary blood vessel to refractory angina pectoris patients Refractory angina pectoris patients in Harapan Kita hospitals who do not respond to drugs adequately will be divided by 2 groups, control & treatment. Inclusion criteria include age 21 - 80 years, Refractory angina CCS III-IV whom are not candidate for Re-revascularization with proven data of: have stenosis on left main more than 50%, stenosis on main coronary right artery more than 70% or stenosis more than 70% on others vessels, conducted in coronary surgery conference with conservative decision (optimal medications).

Exclusion criteria include aorta aneurysm, abdominal aneurysm, acute coronary syndrome, acute heart failure, heavy aortic regurgitation, malignant arrhythmia, blood pressure above 180/100mmHg, acute limb ischemia, DVT, active thrombophlebitis, and pregnancy.

the investigator conducts a double-blind randomized control trial. The participants will get 35 hours ECP treatment, initial treatment pressure is 300 mmHg. whilst control groups will get 75mmHg. At the end of treatment, the investigator compare the hemodynamic effect on coronary perfusion, endothelial function, angiogenesis, and coronary blood vessel arteriogenesis. Quality of Life Improvement based on WHO-5 between groups ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03991871
Study type	Interventional
Source	National Cardiovascular Center Harapan Kita Hospital Indonesia
Contact	Ade Meidian Ambari, MD,FIHA
Phone	628119644123
Email	dr_ade_meidian@yahoo.co.id
Status	Recruiting
Phase	N/A
Start date	July 1, 2019
Completion date	August 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05956912` - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Active, not recruiting	`NCT05773287` - Targeted Health Coaching to Improve Physical Activity Post-Structured Cardiac Rehabilitation	N/A
Completed	`NCT05551429` - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Completed	`NCT02542163` - Pilot Evaluation of the NimbleHeart Harness System in Cardiac Rehabilitation (PEN-CR)	N/A
Not yet recruiting	`NCT05989594` - Home-based Mobile Guided Exercise-based Cardiac Rehabilitation Among Patients Undergoing TAVR	N/A
Active, not recruiting	`NCT05026957` - A Digitally-Supported Shared Decision Making Approach for Coronary Artery Disease Patients During Cardiac Rehabilitation	N/A
Recruiting	`NCT03734185` - Cardiac Rehabilitation: From Hospital to Municipal Setting.	N/A
Recruiting	`NCT05826587` - Cardiac Rehabilitation Mobile-Health Fall Risk Prevention Intervention	N/A
Completed	`NCT03174106` - Longterm Follow-up of Cardiac Patients With an Smartphone-Application	N/A
Recruiting	`NCT05725655` - Hot Water Immersion After Myocardial Infarction	N/A
Not yet recruiting	`NCT05019157` - Cardiac Telerehabilitation Effectiveness Using Wearable Sensors	N/A
Recruiting	`NCT06025526` - Effectiveness of the Aktivplan Digital Intervention (ACTIVE-CaRe Pilot)	N/A
Recruiting	`NCT05099692` - CHD Patient's Concern on Cardiac Rehabilitation
Completed	`NCT06306235` - Are Non-participants of Conventional Centre-based Cardiac Rehabilitation Willing to Participate in Cardiac Telerehabilitation?
Recruiting	`NCT06039969` - Evaluate Aerobic Exercise on Myocardial Fibrosis and Intestinal Flora in Dilated Cardiomyopathy Diagnosed First Time.
Not yet recruiting	`NCT06065319` - Wearables and Cardiac Rehabilitation
Recruiting	`NCT06127537` - Study on the Efficacy of HE and Therapeutic Group Factors on CR and QoL	N/A
Completed	`NCT04738383` - Feasibility and Acceptance of Changes in Medical Supervision of Exercise Groups in Cardiac Rehabilitation	N/A
Active, not recruiting	`NCT03922529` - Modified Application of Cardiac Rehabilitation for Older Adults	N/A
Completed	`NCT00956657` - Improving Cardiac Rehabilitation Session Attendance: A Randomised Controlled Trial	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

HARapan kiTa ECP (External Counter Pulsation) Study HARTEC Study — HARTEC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms